Werewolf Therapeutics, Inc. (NASDAQ:HOWL) has 51 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 6,681,307 | 0 | 0.00% | $4,232,608.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,408,047 | 0 | 0.00% | $892,702.00 |
| MPM BioImpact LLC | 31 Dec, 2025 | 1,393,557 | -1,015,253 | -42.15% | $883,515.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 737,550 | -2,923,034 | -79.85% | $466,869.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 677,766 | 221,766 | 48.63% | $429,365.00 |
| Lynx1 Capital Management LP | 31 Dec, 2025 | 655,926 | 655,926 | 0.00% | $415,529.00 |
| SPHERA FUNDS MANAGEMENT LTD. | 31 Dec, 2025 | 626,810 | 0 | 0.00% | $397,084.00 |
| DC Funds, LP | 31 Dec, 2025 | 589,102 | 0 | 0.00% | $373,196.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 335,886 | 5,099 | 1.54% | $212,838.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 240,109 | -76,944 | -24.27% | $152,109.00 |
| Alyeska Investment Group, L.P. | 31 Dec, 2025 | 235,705 | 0 | 0.00% | $149,319.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 157,322 | -111,255 | -41.42% | $99,663.00 |
| State Street Corp | 31 Dec, 2025 | 119,168 | 0 | 0.00% | $75,493.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 101,643 | 320 | 0.32% | $64,391.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 99,829 | 6,788 | 7.30% | $63,242.00 |
| Northern Trust Corp | 31 Dec, 2025 | 86,851 | 21,015 | 31.92% | $55,020.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 77,000 | -25,000 | -24.51% | $48,780.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 68,146 | 7,805 | 12.93% | $43,170.00 |
| UBS Group AG | 31 Dec, 2025 | 60,708 | 47,932 | 375.17% | $38,428.00 |
| Vontobel Holding Ltd. | 31 Dec, 2025 | 60,003 | 24,003 | 66.68% | $38,012.00 |